Quick Answer
Adaptive Biotechnologies Corp reported Common Stock Shares Outstanding of 153.78 million shares for the year ending 2025.
- Adaptive Biotechnologies Corp showed an increase of +4.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Adaptive Biotechnologies Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: 13.73 million shares | Q3 2019: 124.32 million shares | Q1 2020: 126.62 million shares | Q2 2020: 128.23 million shares | Q3 2020: 136.39 million shares | Q1 2021: 139.88 million shares | Q2 2021: 140.66 million shares | Q3 2021: 141.03 million shares | Q1 2022: 142.18 million shares | Q2 2022: 142.78 million shares | Q3 2022: 142.99 million shares | Q1 2023: 144.28 million shares | Q2 2023: 144.65 million shares | Q3 2023: 144.77 million shares | Q1 2024: 147.37 million shares | Q2 2024: 147.46 million shares | Q3 2024: 147.56 million shares | Q1 2025: 151.92 million shares | Q2 2025: 152.23 million shares | Q3 2025: 152.58 million shares.
- Over the full 8 years of available data (2018 to 2025), Adaptive Biotechnologies Corp's Common Stock Shares Outstanding has grown by 1,097.5%.
- Historical annual values: Fiscal year 2025: 153.78 million shares | Fiscal year 2024: 147.77 million shares | Fiscal year 2023: 145.08 million shares | Fiscal year 2022: 143.11 million shares | Fiscal year 2021: 141.39 million shares | Fiscal year 2020: 137.65 million shares | Fiscal year 2019: 125.24 million shares | Fiscal year 2018: 12.84 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: